Harriet Kluger MD

Professor of Medicine (Medical Oncology); Associate Director, Hematology/Oncology Fellowship Program

Departments & Organizations

Cancer Center, Yale: Prostate and Urologic Cancers Program | Melanoma Program | Developmental Therapeutics

Skin Diseases Research Center, Yale

SPORE in Skin Cancer

Medical Oncology

Immunology and Immunotherapy

General Urology

Medical Oncology


Dr. Kluger is a medical oncologist who sees patients with melanoma and renal cell carcinoma. Her research interests focus on developing new drugs and biomarkers predictive of response to these drugs in melanoma and renal cell carcinoma. She participates in a number of clinical trials studying new agents for the treatment of these diseases, both targeting the immune system and the cancer cell. She runs and active research laboratory that studies tumors and cells from patients treated with novel therapies.


  • M.D., Tel Aviv University , 1993

Selected Publication

  • C-Raf is Associated with Disease Progression and Inhibition of Apoptosis in a Subset of Melanomas Jilaveanu LB, Zito C, Aziz SA, Schmitz JC, Sznol M, Camp RL, Rimm DL, and Kluger HM 2009 Sep 15;15(18):5704-13, Clinical Cancer Research
Download on the Apple App Store